Improving Care for Heart Failure With Reduced Ejection Fraction (HFrEF) —A Polypill-Based Strategy
This Viewpoint proposes that a polypill combination of a β-blocker, renin angiotensin inhibitor, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter 2 inhibitor might be the most efficient way to deliver guideline-directed HFrEF therapy, and proposes a research roadmap to design and evaluate the pill and implementation strategies for getting it to patients.
Source: JAMA - Category: General Medicine Source Type: research